Golden
Chimera Bioengineering

Chimera Bioengineering

Chimera Bioengineering is a biotechnology company developing cell therapies to treat cancer.

Chimera Bioengineering is a biotechnology company developing cell therapies to treat cancer that is headquartered in South San Francisco, California and was founded in 2015 by ben Wang, Christina Smolke, and Gusti Zeiner.

Funding

Venture round

On November 16, 2016 Chimera Bioengineering raised an undisclosed amount of venture capital funding from The Angel's Forum and Sand Hill Angels. 

Seed

On August 25, 2017 Chimera Bioengineering completed their seed funding round with an undisclosed amount of funding from Kairos Venture Investments. 



Timeline

August 25, 2017

Seed funding round

On August 25, 2017 Chimera Bioengineering completed their seed funding round with an undisclosed amount of funding from Kairos Venture Investments. 

November 16, 2016

Venture funding round

On November 16, 2016 Chimera Bioengineering raised an undisclosed amount of venture capital funding from The Angel's Forum and Sand Hill Angels. 

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date

Illumina Accelerator in the Bay Area Makes Room for 5 New Biotech Startups

BioSpace

Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References